TORNTPHARM vs ZYDUSLIFE: Stock Comparison

Head-to-head financial and trading comparison between Torrent Pharmaceuticals Limited (TORNTPHARM) and Zydus Lifesciences Limited (ZYDUSLIFE) in the Pharmaceuticals & Healthcare sector.

TORNTPHARM

NSE: TORNTPHARM
Torrent Pharmaceuticals Limited
₹4,767.30
1Y Return: +14.73%
52W High: ₹5,122.80
52W Low: ₹4,084.60
Annual Volatility: 21.87%
Check TORNTPHARM Trade Fees →

ZYDUSLIFE

NSE: ZYDUSLIFE
Zydus Lifesciences Limited
₹1,145.70
1Y Return: +25.16%
52W High: ₹1,215.00
52W Low: ₹891.90
Annual Volatility: 27.28%
Check ZYDUSLIFE Trade Fees →

Key Metrics Comparison Table

MetricTORNTPHARMZYDUSLIFEEdge / Winner
Current Market Price (CMP) ₹4,767.30 ₹1,145.70 —
1-Year Price Return +14.73% +25.16% ZYDUSLIFE (10.43% higher)
52-Week High ₹5,122.80 ₹1,215.00 —
52-Week Low ₹4,084.60 ₹891.90 —
30-Day Annualized Volatility 21.87% 27.28% TORNTPHARM (Steadier)
30-Day Average Daily Volume 330,318 1,510,992 ZYDUSLIFE (Higher Liquidity)
Statutory Cost to Trade ₹1 Lakh ₹118.50 ₹118.50 Identical statutory tariff

Frequently Asked Questions

Between TORNTPHARM and ZYDUSLIFE, which stock gave better returns over the last year?

ZYDUSLIFE has outperformed TORNTPHARM over the past 12 months with a gain of 25.16% compared to 14.73%.

Which stock is less volatile: TORNTPHARM or ZYDUSLIFE?

TORNTPHARM demonstrated lower price volatility (21.87% annualized) compared to ZYDUSLIFE (27.28%). Lower volatility generally indicates steadier price action during market downturns.

What is the statutory cost to buy ₹1,00,000 of TORNTPHARM vs ZYDUSLIFE?

Statutory exchange and government charges (STT, NSE turnover fees, SEBI fee, Stamp duty, and GST) are identical for delivery purchases of equal rupee value across both stocks, totaling approximately ₹118.50 on discount brokers offering zero delivery brokerage (like Zerodha or Dhan).

Are TORNTPHARM and ZYDUSLIFE direct sector competitors?

Yes, both companies operate within the Pharmaceuticals & Healthcare sector in India and are actively tracked as sector peers by institutional and retail market participants.